Keywords: Elbasvir; Grazoprevir; Simultaneous analysis; Zepatier;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Keywords: chronic kidney disease; DAA; elbasvir; grazoprevir; HCV; hemodialysis;
A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese Participants
Keywords: elbasvir; grazoprevir; pharmacokinetics;
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3
Keywords: elbasvir; genotype 1; genotype 3; grazoprevir; hepatitis C virus; monotherapy;
Consenso Mexicano para el Tratamiento de la Hepatitis C
Keywords: Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; AAD; antivirales de acción directa; AASLD; Asociación Americana para el Estud
The Mexican consensus on the treatment of hepatitis C
Keywords: Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major
Keywords: PRC; packed red blood cells; HIV; human immunodeficiency virus; DAAs; direct acting antivirals; SVR; sustained virological response; RNA; ribonucleic acid; VAS; visual analogue scale; RVR; rapid virological response; EBR; elbasvir; GZR; grazoprevir; SD; s
Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?
Keywords: CTP; Child-Turcotte-Pugh staging; CSA; cyclosporine A; DAA; directly acting antivirals; DCV; daclatasvir; DDLT; deceased donor liver transplant; DSB; dasabuvir; EBV; elbasvir; FCH; fibrosing cholestatic hepatitis; GT; genotype; GRZ; grazoprevir; HCV;
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
Keywords: Hepatitis C; Randomized; Therapy; C-EDGE Treatment-Experienced; AE; adverse event; ALT; alanine aminotransferase; ART; antiretroviral therapy; CI; confidence interval; EBR; elbasvir; GT; genotype; GZR; grazoprevir; HCV; hepatitis C virus; HIV; human immun
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors
Keywords: HCV NS5A inhibitor; Elbasvir; MK-8742; Direct-acting antiviral agents; DAA; HCV infection treatment; Tetracyclic core;
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742
Keywords: BVAZQCUMNICBAQ-PZHYSIFUSA-N; WPYAXRMKAPEASP-ZPGYEBBTSA-N; YMRDJTQTNBXZGH-GKQJGOKYSA-N; DAGKKAIYGHXLJT-VPYCOWAPSA-N; YRKMHJVTILGOJX-MZGVRTMSSA-N; QEKPBCIKIXADMU-VPYCOWAPSA-N; ZXSYHNKPSRDAKS-BWNUEVLRSA-N; MGZRWHFXUDRFCO-QSGJOOOQSA-N; CCBTWTUTQJQYAP-MDIMQYHW
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitors
Keywords: HCV NS5A inhibitor; Elbasvir; MK-8742; Direct-acting antiviral agents; HCV infection treatment; Indole based tetracyclic core;
Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study
Keywords: Elbasvir; Deuterated elbasvir; UPLC-MS/MS; Plasma; Pharmacokinetics; Rat;
Research ArticleGrazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Keywords: DAA; Direct-acting antiviral agents; PR; Peginterferon alfa and ribavirin; RAV; Resistance-associated variants; SVR; Sustained virologic response; C-SALVAGE; HCV genotype-1; Grazoprevir; Elbasvir; Direct-acting antiviral agents;
Clinical Trial Watch: Reports from the EASL International Liver Congress (ILC), Vienna, April 2015
Keywords: SOF; Sofosbuvir; DCV; Daclatasvir; RBV; Ribavirin; CP; Child-Pugh; SVR; Sustained virologial response; HVPG; Hepatic venous pressure gradient; G; Genotype; LDV; Ledipasvir; GZR; grazoprevir; EBR; Elbasvir; SMV; Simeprevir; CKD; Chronic kidney disease; RAV